A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients
PHASE1
A double-blind, randomized, placebo-controlled, dose-escalating study to as...
Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors
N/A
This is a single-site substudy, "Investigation of the Effect of Cenicriviro...
Status
Terminated
Location
University of California, San Francisco; San Francisco General Hospital
Start Date
2011-09
Trial ID
NCT01474954
Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus
PHASE2
This is a randomized, double-blind, double-dummy, 48-week, comparative stud...